https://www.selleckchem.com/products/imdk.html
Twenty months post-surgery, the patient remains disease-free and without any evidence of panniculitis. Due to the rarity of pancreatic acinar cell carcinoma, guidelines based on prospective data do not exist. Most management is based on retrospective analyses. A survival benefit may be achieved with more aggressive surgical management compared to other pancreatic cancer types. Pancreatic acinar cell carcinoma may show a slower rate of disease progression, an increased likelihood of resectability of disease at presentation and is more likel
Like
Comment
Share
